Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid moiety from UDP-glucuronic acid to the substrate, forming a glucuronide conjugate. This conjugate, being more polar, is swiftly excreted by the kidneys.
The formation of glucuronide involves multiple steps. Initially, the UGT enzyme binds to both the substrate and UDP-glucuronic acid. Following this, the glucuronic acid moiety is transferred to a functional group on the substrate, such as a hydroxyl (–OH), amine (–NH2), thiol (–SH), or carboxyl (–COOH) group, resulting in a glucuronide metabolite. Depending on the site of conjugation, there are various types of glucuronides. O-glucuronides involve the attachment of glucuronic acid with a hydroxyl group, N-glucuronides with an amine group, S-glucuronides with a thiol group, and C-glucuronides with a carbon atom.
Several commonly used drugs, such as acetaminophen, morphine, and ibuprofen, undergo glucuronidation. For instance, acetaminophen is metabolized into a glucuronide conjugate before urinary excretion. Morphine transforms into morphine-3-glucuronide, a polar and less active metabolite, while ibuprofen is metabolized into an inactive glucuronide conjugate. In addition to these, antidepressants like amitriptyline and HIV medications such as raltegravir also undergo glucuronidation. This reaction plays a significant role in metabolizing various drugs across different therapeutic classes, ensuring their effective elimination and reducing their potential toxicity.
Glucuronidation, a key phase II biotransformation reaction, involves the conjugation of glucuronic acid to xenobiotics or metabolites.
This process is abundant in body tissues and employs D-glucuronic acid, derived endogenously from D-glucose. D-glucuronic acid forms conjugates with diverse functional groups.
The enzymes catalyzing this reaction, called UGTs, are closely associated with the microsomal mixed-function oxidases.
Glucuronide formation is initiated by the synthesis of an activated coenzyme, followed by the transfer of a glucuronyl moiety to the substrate.
O-glucuronides form when glucuronic acid binds to oxygen in the substrate's carboxylic acid or hydroxyl group.
N-glucuronides form when glucuronic acid is attached to nitrogen in amine, amide, or sulfonamide-containing drugs.
S- and C-glucuronides form when the glucuronyl moiety is linked to a thiolic sulfur and nucleophilic carbon, respectively.
These reactions significantly enhance drug hydrophilicity, aiding detoxification and facilitating excretion.
繁體中文
